Literature DB >> 28869889

IL-36 induces cytokine IL-6 and chemokine CXCL8 expression in human lung tissue cells: Implications for pulmonary inflammatory responses.

Juan Zhang1, Yibing Yin2, Xue Lin3, Xingxing Yan3, Yun Xia3, Liping Zhang3, Ju Cao4.   

Abstract

IL-36α, IL-36β and IL-36γ are cytokine members of IL-1 family. Although IL-36 expression was observed in human lung during pulmonary infections, it remains unknown whether IL-36 could act directly on lung tissue cells during pulmonary inflammatory responses. In this study, we showed that IL-36 receptor was expressed in human lung fibroblasts and bronchial epithelial cells. Correspondingly, IL-36α, IL-36β or IL-36γ up-regulated gene expression of cytokine IL-6 and chemokine CXCL8 in human lung fibroblasts and bronchial epithelial cells, and promoted IL-6 and CXCL8 release from human lung fibroblasts and bronchial epithelial cells. The production of IL-6 and CXCL8 in these lung tissues cells induced by IL-36α, IL-36β or IL-36γ was regulated by p38MAPK, ERK or Akt signaling pathways. Taken together, the above results suggest that IL-36-mediated IL-6 and CXCL8 production in human lung fibroblasts and bronchial epithelial cells may be involved in pulmonary inflammation especially caused by bacterial or viral infections.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Human bronchial epithelial cells; Human lung fibroblast; IL-36; Inflammation; Lung

Mesh:

Substances:

Year:  2017        PMID: 28869889     DOI: 10.1016/j.cyto.2017.08.022

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  11 in total

1.  IL-36γ induces a transient HSV-2 resistant environment that protects against genital disease and pathogenesis.

Authors:  Jameson K Gardner; Melissa M Herbst-Kralovetz
Journal:  Cytokine       Date:  2018-08-15       Impact factor: 3.861

2.  IL-36 is Closely Related to Neutrophilic Inflammation in Chronic Obstructive Pulmonary Disease.

Authors:  Siyuan Huang; Tao Feng; Jing Wang; Liang Dong
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-06-07

3.  Neutrophil extracellular traps activate IL-8 and IL-1 expression in human bronchial epithelia.

Authors:  Kristin M Hudock; Margaret S Collins; Michelle Imbrogno; John Snowball; Elizabeth L Kramer; John J Brewington; Kandace Gollomp; Cormac McCarthy; Alicia J Ostmann; Elizabeth J Kopras; Cynthia R Davidson; Anusha Srdiharan; Paritha Arumugam; Shaon Sengupta; Yan Xu; G Scott Worthen; Bruce C Trapnell; John Paul Clancy
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-03-11       Impact factor: 5.464

Review 4.  Interleukin-36: Structure, Signaling and Function.

Authors:  Li Zhou; Viktor Todorovic
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 5.  IL-36 in chronic inflammation and fibrosis - bridging the gap?

Authors:  Michael Elias; Shuai Zhao; Hongnga T Le; Jie Wang; Markus F Neurath; Clemens Neufert; Claudio Fiocchi; Florian Rieder
Journal:  J Clin Invest       Date:  2021-01-19       Impact factor: 14.808

6.  Acute Effects of the Consumption of Passiflora setacea Juice on Metabolic Risk Factors and Gene Expression Profile in Humans.

Authors:  Isabella de Araújo Esteves Duarte; Dragan Milenkovic; Tatiana Karla Dos Santos Borges; Artur Jordão de Magalhães Rosa; Christine Morand; Livia de Lacerda de Oliveira; Ana Maria Costa
Journal:  Nutrients       Date:  2020-04-16       Impact factor: 5.717

7.  IL-36 receptor agonist and antagonist imbalance drives neutrophilic inflammation in COPD.

Authors:  Jonathan R Baker; Peter S Fenwick; Carolin K Koss; Harriet B Owles; Sarah L Elkin; Jay Fine; Matthew Thomas; Karim C El Kasmi; Peter J Barnes; Louise E Donnelly
Journal:  JCI Insight       Date:  2022-08-08

Review 8.  The Role of IL-36 in Infectious Diseases: Potential Target for COVID-19?

Authors:  Xiaofang Wang; Panpan Yi; Yuejin Liang
Journal:  Front Immunol       Date:  2021-05-13       Impact factor: 7.561

9.  Evidence that Maackia amurensis seed lectin (MASL) exerts pleiotropic actions on oral squamous cells to inhibit SARS-CoV-2 infection and COVID-19 disease progression.

Authors:  Stephanie A Sheehan; Kelly L Hamilton; Edward P Retzbach; Premalatha Balachandran; Harini Krishnan; Paola Leone; Gary S Goldberg
Journal:  Res Sq       Date:  2020-10-23

Review 10.  IL-36 cytokines in inflammatory and malignant diseases: not the new kid on the block anymore.

Authors:  James Byrne; Kevin Baker; Aileen Houston; Elizabeth Brint
Journal:  Cell Mol Life Sci       Date:  2021-08-07       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.